Skip to Main Content

Hello, everyone, and how are you today? A shiny sun and delightful breeze are enveloping the Pharmalot campus this morning, where the short person is hunched over a laptop and the official mascot is happily snoozing. As for us, we are staring at the intimidating to-do list and quaffing cups of stimulation. Perhaps you can relate? In any event, we have once again assembled a few items of interest to get you started on your day. So here you go. Hope you conquer the world, and keep us in mind when you run across something intriguing. …

The Biden administration met privately this month with some of the nation’s biggest health care companies and lobbying organizations to discuss how to rework the health care supply chain, STAT reports. Some 30 companies, including 3M (MMM), AmerisourceBergen (ABC), and Dupont (DD) were invited to a private “workshop” held via WebEx on April 5, along with lobbying groups representing drug makers, hospitals, pharmacists, and drug distributors.


Several branches of the European Commission have stayed in close contact with the European pharmaceutical industry trade group since the outbreak of the pandemic, Corporate Europe Observatory says. These included meetings with EU civil servants to discuss how to secure stronger rules on intellectual property rights in bilateral trade agreements as well as enforcement. Intellectual property rights, including patents, on Covid-19 vaccines and medicines have been a key battleground worldwide since early in the pandemic.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!